Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of $0.3 million, compared to a loss of $0.05 million in Q3 2024Cash position of $2.0 million as of August 31, 2024Subsequent to Quarter EndOn December 12, 2024, the Company closed on the sale of its wellness clinic network to Stella, an interventional psychiatry practice, for a total consideration of US$3.53 million. As a result of the transaction, the Company's U.S. Clinic Network operating segment has been classi ...

Vancouver, British Columbia--(Newsfile Corp. - July 25, 2025) - MineHub Technologies Inc. (TSXV: MHUB) (OTCQB: MHUBF) ("MineHub" or the "Company") announces that it has closed its non-brokered private placement previously announced on July 2, 2025 (the "Offering"). The Offering raised aggregate gross proceeds of CAD $500,000 through the sale of 1,250,000 units ("Units") at a price of $0.40 per Unit. Each Unit consists of one common share in the capital of the Company (each, a "Common Share") and one-half o ...

Edmonton, Alberta--(Newsfile Corp. - July 25, 2025) - Everyday People Financial Corp. (TSXV: EPF) (OTCQB: EPFCF) ("Everyday People" or the "Company"), a technology-driven financial services provider, headquartered in Edmonton, Alberta, is pleased to announce it will hold its annual and special meeting of its shareholders to be held virtually on Monday, September 29, 2025 (the "Meeting"). The record date for determination of the shareholders entitled to receive notice of, and to vote at, the Meeting or any ...

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Metalite Resources Inc. (CSE: METL) (OTC Pink: JNCCF) (FSE: D68) ("Metalite" or the "Company") announces the consolidation of the outstanding common shares in the capital of the Company (each, a "Common Share") on the basis of one post-consolidation Common Share for every ten pre-consolidation Common Shares as at July 25, 2025 (the "Consolidation"). It is anticipated that the Common Shares will begin trading on a consolidated basis at market opening on J ...

Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) ("Avalon" or the "Company") is pleased to announce that it has closed the $1,300,000 second drawdown of its up to $15,000,000 convertible security funding agreement (the "Funding Agreement") with Lind Global Fund II, LP, an entity managed by The Lind Partners, a New York based institutional fund manager (together "Lind"). The details of the Funding Agreement are contained in the Company's news rele ...

Bedford, Nova Scotia--(Newsfile Corp. - July 25, 2025) - Sylla Gold Corp. (TSXV: SYG) (OTC Pink: SYGCF) ("Sylla" or the "Company") announces that, further to its press release of June 6, 2025, the TSX Venture Exchange (the "TSXV") has approved the issuance of an aggregate of 599,998 common shares (each, a "Common Share") in the capital of the Company at a deemed price of $0.015 per Common Share, in connection with its unsecured promissory notes (the "Notes"), dated June 6, 2025, in the principal amount of ...

Vancouver, British Columbia--(Newsfile Corp. - July 25, 2025) - RUMBLE RESOURCES INC. (CSE: RB) (the "Company" or "Rumble"), is pleased to announce that, further to its news release dated June 11, 2025, the Company has completed its non-brokered private placement of 7,000,000 units (the "Units") at a price of $0.075 per Unit for proceeds of $525,000. Each Unit consists of one common share and one two-year transferable share purchase warrant entitling the holder to acquire an additional common share for $0. ...

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross ProceedsJuly 25, 2025 3:04 PM EDT | Source: Phio Pharmaceuticals Corp.King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today announced the entry into definitive agreements to exercise certain outsta ...

Phio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth CohortJuly 25, 2025 12:36 PM EDT | Source: Phio Pharmaceuticals Corp.Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4 metastatic Merkel cell patientKing of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary I ...

Stonegate Updates Coverage on Third Coast Bancshares, Inc. (TCBX) Q2 2025July 25, 2025 9:36 AM EDT | Source: Reportable, Inc.Dallas, Texas--(Newsfile Corp. - July 25, 2025) - Third Coast Bancshares, Inc. (Nasdaq: TCBX): Stonegate Capital Partners updates their coverage on Third Coast Bancshares, Inc. For 2Q25, Third Coast reported net income of $16.8M, which is up from $13.6M in 1Q25. This was equal to a basic and diluted EPS of $1.12 and $0.96, respectively. The Q/Q increase was primarily att ...